Comment on ‘Fluocinolone Acetonide Intravitreal Implant for Treating Recurrent Non-infectious Uveitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal’

被引：0
|
作者：
Ian Jacob
Karin Butler
Karolina Badora
Vanessa Gross
Annette Beiderbeck
Steve Morris
Phil McEwan
机构：
[1] Health Economics and Outcomes Research Ltd,
[2] Alimera Sciences Ophthalmologie GmbH,undefined
[3] Alimera Sciences Ltd,undefined
来源：
PharmacoEconomics | 2020年 / 38卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：645 / 648
页数：3
相关论文
共 50 条
  • [21] Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye – evaluating the 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN®)
    Bahram Bodaghi
    Quan Dong Nguyen
    Glenn Jaffe
    Ramin Khoramnia
    Carlos Pavesio
    Journal of Ophthalmic Inflammation and Infection, 10
  • [22] Treatment of non-infectious uveitis that affects the posterior segment with a single intravitreal fluocinolone acetonide insert (FAi)-3-year results
    Jaffe, Glenn J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [23] Fluocinolone acetonide 0.18-mg implant for treatment of recurrent inflammation due to non-infectious uveitis: a case series of 15 patients
    Sisk, Robert A.
    Kiernan, Daniel F.
    Almeida, David
    Kolomeyer, Anton M.
    Eichenbaum, David
    Kitchens, John W.
    JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION, 2024, 14 (01):
  • [24] Efficacy of 0.19 mg Fluocinolone Acetonide Implant in Non-infectious Posterior Uveitis Evaluated as Area Under the Curve
    Marco Battista
    Vincenzo Starace
    Maria Vittoria Cicinelli
    Luigi Capone
    Alessandro Marchese
    Giulio Modorati
    Francesco Bandello
    Elisabetta Miserocchi
    Ophthalmology and Therapy, 2022, 11 : 215 - 224
  • [25] Real-World Efficacy and Side Effects of the Fluocinolone Acetonide Implant (FAi) in Eyes with Non-infectious Uveitis
    Valadez, Jullian James
    Ji, Xiangyu
    Chen, Qingxia
    Kim, Stephen
    Gangaputra, Sapna
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [26] Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema
    Lea F. Weber
    Stefanie Marx
    Gerd U. Auffarth
    Alexander F. Scheuerle
    Tamer Tandogan
    Christian Mayer
    Ramin Khoramnia
    Journal of Ophthalmic Inflammation and Infection, 9
  • [27] The fluocinolone acetonide implant in chronic non-infectious uveitis with posterior segment involvement: Experience in a Dutch clinical setting
    Heesterbeek, T. J.
    Tan, H. S.
    de Hoog, J.
    ACTA OPHTHALMOLOGICA, 2023, 101 : 43 - 43
  • [28] Mepolizumab for Treating Severe Eosinophilic Asthma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
    Bermejo, Inigo
    Stevenson, Matt
    Cooper, Katy
    Harnan, Sue
    Hamilton, Jean
    Clowes, Mark
    Carroll, Christopher
    Harrison, Tim
    Saha, Shironjit
    PHARMACOECONOMICS, 2018, 36 (02) : 131 - 144
  • [29] Ponatinib for Treating Acute Lymphoblastic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
    Matt Stevenson
    Abdullah Pandor
    Jean Hamilton
    John Stevens
    Clare Rowntree
    Marrissa Martyn-St James
    Andrew Rawdin
    Ruth Wong
    PharmacoEconomics, 2018, 36 : 759 - 768
  • [30] Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
    Mistry, Hema
    Nduka, Chidozie
    Connock, Martin
    Colquitt, Jill
    Mantopoulos, Theodoros
    Loveman, Emma
    Walewska, Renata
    Mason, James
    PHARMACOECONOMICS, 2018, 36 (04) : 399 - 406
12345